This is a Validated Antibody Database (VAD) review about rat Hras, based on 68 published articles (read how Labome selects the articles), using Hras antibody in all methods. It is aimed to help Labome visitors find the most suited Hras antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Hras synonym: HRAS1; c-H-ras

Knockout validation
Abcam
domestic rabbit monoclonal (Y132)
  • western blot knockout validation; human; 1:1000; fig s2
Abcam Hras antibody (Abcam, ab32417) was used in western blot knockout validation on human samples at 1:1000 (fig s2). Cell Death Dis (2016) ncbi
Abcam
mouse monoclonal
  • western blot; human; 1:200; loading ...; fig 1a
Abcam Hras antibody (Abcam, ab55391) was used in western blot on human samples at 1:200 (fig 1a). elife (2019) ncbi
domestic rabbit monoclonal (EPR3255)
  • western blot; human; 1:1000; loading ...; fig e2b
Abcam Hras antibody (Abcam, ab108602) was used in western blot on human samples at 1:1000 (fig e2b). Nature (2019) ncbi
domestic rabbit monoclonal (EPR3255)
  • western blot; Caenorhabditis elegans; loading ...; fig 10e
Abcam Hras antibody (Abcam, EPR3255) was used in western blot on Caenorhabditis elegans samples (fig 10e). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (EPR3255)
  • western blot; human; fig 3b
Abcam Hras antibody (Abcam, ab108602) was used in western blot on human samples (fig 3b). Cell (2018) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; loading ...; fig 4a
In order to determine the effects of High mobility group box 1 on cytokine secretion from mesenchymal stem cells, Abcam Hras antibody (Abcam, ab52939) was used in western blot on human samples (fig 4a). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; fig 4c
In order to explore how C-kinase potentiated protein phosphatase-1 inhibitor of 17 kDa drives Ras activity and tumorigenesis, Abcam Hras antibody (Abcam, EP1125Y) was used in western blot on human samples (fig 4c). Oncotarget (2016) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig 1
Abcam Hras antibody (Abcam, ab55391) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Y132)
  • western blot knockout validation; human; 1:1000; fig s2
Abcam Hras antibody (Abcam, ab32417) was used in western blot knockout validation on human samples at 1:1000 (fig s2). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; loading ...; fig 5c
Abcam Hras antibody (Abcam, ab52939) was used in western blot on human samples (fig 5c). Oncotarget (2016) ncbi
mouse monoclonal (F132-62)
  • immunocytochemistry; human; loading ...; fig 2c
In order to describe the antitumoral mechanism of vitamin C in KRAS mutant colorectal cancer that is related to the Warburg effect, Abcam Hras antibody (Abcam, ab16907) was used in immunocytochemistry on human samples (fig 2c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Y132)
  • western blot; rat; fig 5
In order to characterize and identify PSD-95 depalmitoylating enzymes, Abcam Hras antibody (Abcam, ab32417) was used in western blot on rat samples (fig 5). J Neurosci (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human; fig s2
Abcam Hras antibody (Abcam, ab52939) was used in western blot on human samples (fig s2). Sci Rep (2015) ncbi
mouse monoclonal
  • western blot; human; 1:500; loading ...; fig 3d
Abcam Hras antibody (Abcam, ab55391) was used in western blot on human samples at 1:500 (fig 3d). J Pathol (2016) ncbi
mouse monoclonal
  • western blot; mouse; 1:1000; fig 5a
Abcam Hras antibody (Abcam, ab55391) was used in western blot on mouse samples at 1:1000 (fig 5a). Mol Cancer Ther (2015) ncbi
mouse monoclonal
  • western blot; human; fig 1
In order to investigate Ras dimerization-dependent signaling, Abcam Hras antibody (Abcam, ab55391) was used in western blot on human samples (fig 1). Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit monoclonal (EPR3255)
  • immunoprecipitation; human; 1:1000; fig 2
  • immunocytochemistry; human; 1:25; fig 5
  • western blot; human; fig 5
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 6
Abcam Hras antibody (Abcam, ab108602) was used in immunoprecipitation on human samples at 1:1000 (fig 2), in immunocytochemistry on human samples at 1:25 (fig 5), in western blot on human samples (fig 5) and in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6). Oncogene (2016) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig 2a
Abcam Hras antibody (Abcam, ab55391) was used in western blot on human samples (fig 2a). Mol Carcinog (2016) ncbi
domestic rabbit monoclonal (EP1125Y)
  • western blot; human
In order to study the ERbB signaling network with a view to understanding the basis for context-specific signaling plasticity, Abcam Hras antibody (Abcam, ab52939) was used in western blot on human samples . Sci Signal (2013) ncbi
domestic rabbit monoclonal (Y132)
  • western blot; human
Abcam Hras antibody (Abcam, ab32417) was used in western blot on human samples . J Biol Chem (2013) ncbi
domestic rabbit monoclonal (EP1125Y)
  • immunoprecipitation; human
  • western blot; human
Abcam Hras antibody (Abcam, ab52939) was used in immunoprecipitation on human samples and in western blot on human samples . Biochem J (2013) ncbi
domestic rabbit monoclonal (Y132)
  • western blot; human
Abcam Hras antibody (Abcam, ab32417) was used in western blot on human samples . Cell Cycle (2012) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F235)
  • western blot; human; 1:200; loading ...; fig 5c
Santa Cruz Biotechnology Hras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:200 (fig 5c). J Cell Mol Med (2019) ncbi
mouse monoclonal (F235)
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology Hras antibody (SantaCruz, 29) was used in western blot on human samples (fig 2c). Mol Cell Biol (2017) ncbi
mouse monoclonal (F132)
  • western blot; human; loading ...; fig 7a
In order to explore the role of the S100A7 in oral squamous cell carcinoma, Santa Cruz Biotechnology Hras antibody (Santa Cruz, S-32) was used in western blot on human samples (fig 7a). Cancer Gene Ther (2016) ncbi
mouse monoclonal (F235)
  • western blot; human; 1:500; fig 5b
Santa Cruz Biotechnology Hras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:500 (fig 5b). Nat Commun (2016) ncbi
mouse monoclonal (F235)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
Santa Cruz Biotechnology Hras antibody (Santa Cruz, sc-29) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (F235)
  • western blot; human; 1:50; loading ...; fig 2a
In order to describe how a CHK1 inhibitor reduces the growth of radioresistant breast cancer cells, Santa Cruz Biotechnology Hras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:50 (fig 2a). Oncotarget (2016) ncbi
rat monoclonal (259)
  • immunoprecipitation; human; fig 6
  • western blot; human; fig 6
Santa Cruz Biotechnology Hras antibody (Santa Cruz, sc-35l) was used in immunoprecipitation on human samples (fig 6) and in western blot on human samples (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (C-4)
  • western blot; mouse; fig 1
  • western blot; human; fig 1
Santa Cruz Biotechnology Hras antibody (Santa Cruz Biotechnology, sc-166691) was used in western blot on mouse samples (fig 1) and in western blot on human samples (fig 1). Cell Commun Signal (2016) ncbi
mouse monoclonal (F235)
  • western blot; mouse; fig 1
Santa Cruz Biotechnology Hras antibody (Santa Cruz Biotechnology, sc-29) was used in western blot on mouse samples (fig 1). Oncogene (2016) ncbi
mouse monoclonal (F235)
  • western blot; human; 1:1000
Santa Cruz Biotechnology Hras antibody (Santa Cruz, sc-29) was used in western blot on human samples at 1:1000. Nat Commun (2015) ncbi
mouse monoclonal (F235)
  • western blot; human; fig 1
Santa Cruz Biotechnology Hras antibody (santa Cruz, sc-29) was used in western blot on human samples (fig 1). PLoS Genet (2015) ncbi
mouse monoclonal (F235)
  • western blot; human; fig 2
Santa Cruz Biotechnology Hras antibody (santa Cruz, sc-29) was used in western blot on human samples (fig 2). Oncogene (2015) ncbi
mouse monoclonal (C-4)
  • western blot; human
Santa Cruz Biotechnology Hras antibody (Santa, sc-166691) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (M90)
  • western blot; rat
Santa Cruz Biotechnology Hras antibody (Santa Cruz Biotechnology, M90) was used in western blot on rat samples . Neuropsychopharmacology (2014) ncbi
mouse monoclonal (F235)
  • western blot; human
Santa Cruz Biotechnology Hras antibody (Santa Cruz Biotechnology, sc-29) was used in western blot on human samples . Biochem J (2013) ncbi
mouse monoclonal (F235)
  • western blot; human
Santa Cruz Biotechnology Hras antibody (Santa Cruz, sc-29) was used in western blot on human samples . J Biol Chem (2013) ncbi
Invitrogen
rat monoclonal (Y13-259)
  • other; mouse; loading ...; fig 2a
In order to explore how C-kinase potentiated protein phosphatase-1 inhibitor of 17 kDa drives Ras activity and tumorigenesis, Invitrogen Hras antibody (ThermoFisher Scientific, Y13-259) was used in other on mouse samples (fig 2a). Oncotarget (2016) ncbi
rat monoclonal (Y13-259)
  • immunoprecipitation; mouse; fig 4
In order to determine the role of Ras in solute signaling using a murine inner medullary collecting duct cell line, Invitrogen Hras antibody (Zymed, clone Y13-259) was used in immunoprecipitation on mouse samples (fig 4). Am J Physiol Cell Physiol (2000) ncbi
EMD Millipore
mouse monoclonal (RAS10)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1a
  • western blot; human; 1:3000; loading ...; fig 1c
EMD Millipore Hras antibody (Millipore, 05-516) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1a) and in western blot on human samples at 1:3000 (fig 1c). Nat Commun (2019) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 3f
EMD Millipore Hras antibody (Merck Millipore, 05-516) was used in western blot on human samples (fig 3f). Science (2018) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; loading ...; fig 2b, 3e
  • western blot; human; loading ...; fig 4f
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on mouse samples (fig 2b, 3e) and in western blot on human samples (fig 4f). Nat Med (2018) ncbi
mouse monoclonal (RAS10)
  • immunohistochemistry - paraffin section; human; loading ...; fig s2
  • flow cytometry; human; loading ...; tbl 1
  • immunoprecipitation; human; loading ...; tbl 1
  • immunocytochemistry; human; loading ...; tbl 1
  • ELISA; human; loading ...; tbl 1
  • western blot; human; fig 1b
In order to evaluation isoform- and mutation-specific RAS antibodies, EMD Millipore Hras antibody (Millipore, 05-516) was used in immunohistochemistry - paraffin section on human samples (fig s2), in flow cytometry on human samples (tbl 1), in immunoprecipitation on human samples (tbl 1), in immunocytochemistry on human samples (tbl 1), in ELISA on human samples (tbl 1) and in western blot on human samples (fig 1b). Sci Signal (2017) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 7e
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples (fig 7e). Oncogene (2017) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 6a
EMD Millipore Hras antibody (Millipore, Ras10) was used in western blot on human samples (fig 6a). PLoS ONE (2017) ncbi
mouse monoclonal (RAS 10)
  • western blot; human; loading ...; fig 6a
EMD Millipore Hras antibody (Millipore, Ras10) was used in western blot on human samples (fig 6a). PLoS ONE (2017) ncbi
mouse monoclonal (RAS10)
  • western blot; human; 1:2000; loading ...; fig 4a, 5a
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples at 1:2000 (fig 4a, 5a). Oncol Lett (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 5a
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples (fig 5a). PLoS Med (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; loading ...; fig 1a
  • western blot; hamsters; loading ...; fig 1d
  • western blot; human; loading ...; fig 1a
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on mouse samples (fig 1a), in western blot on hamsters samples (fig 1d) and in western blot on human samples (fig 1a). J Biol Chem (2017) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; loading ...; fig 6c
In order to generate a protocol using Cre-loxP to rescue mice lacking a gene essential for cell survival by expressing the human homolog on the X chromosome, EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on mouse samples (fig 6c). Sci Rep (2016) ncbi
mouse monoclonal
  • western blot; human; 1:500; loading ...; fig 2b
In order to elucidate the role of NOTCH1 in oncogene-induced senescence, EMD Millipore Hras antibody (Calbiochem, OP-23) was used in western blot on human samples at 1:500 (fig 2b). Nat Cell Biol (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; human; loading ...; fig 4
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; loading ...; fig 1e
EMD Millipore Hras antibody (Merck Millipore, 05-516) was used in western blot on mouse samples (fig 1e). Leukemia (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; human; 1:2000; fig 1
  • western blot; mouse; 1:2000; fig 4
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples at 1:2000 (fig 1) and in western blot on mouse samples at 1:2000 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; human; fig 2a
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples (fig 2a). Genes Dev (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; fig 4
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on mouse samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (RAS 10)
  • western blot; human; 1:500; fig 4
In order to characterize colorectal cancer and nuclear localization of YBX1 and uncoupling of EGFR-RAS signaling, EMD Millipore Hras antibody (Merck Millipore, MABS195) was used in western blot on human samples at 1:500 (fig 4). Oncogenesis (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; loading ...; fig 7b
In order to present the role of Kras in B cell lymphopoiesis, EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on mouse samples (fig 7b). J Immunol (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; fig 1
EMD Millipore Hras antibody (millipore, 05-516) was used in western blot on mouse samples (fig 1). Oncogene (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; human; fig 1
In order to elucidate the contribution of leukemogenic Ras signals, EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples (fig 1). Oncogene (2016) ncbi
mouse monoclonal (RAS10)
  • western blot; human; fig 3
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples (fig 3). Nature (2015) ncbi
mouse monoclonal (RAS10)
  • western blot; human; 1:1000
In order to characterize a new Ras/Rap1-specific endopeptidase, EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples at 1:1000. Nat Commun (2015) ncbi
mouse monoclonal (RAS 10)
  • immunoprecipitation; human
EMD Millipore Hras antibody (Millipore, MABS195) was used in immunoprecipitation on human samples . Proteomics Clin Appl (2015) ncbi
mouse monoclonal (RAS10)
  • western blot; rat
EMD Millipore Hras antibody (Millipore, RAS10) was used in western blot on rat samples . Bioorg Med Chem Lett (2014) ncbi
mouse monoclonal (RAS10)
  • western blot; human
EMD Millipore Hras antibody (Millipore, RAS10) was used in western blot on human samples . Mol Cancer Res (2014) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; fig 8
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on mouse samples (fig 8). J Biol Chem (2014) ncbi
mouse monoclonal (RAS10)
  • western blot; human
EMD Millipore Hras antibody (Calbiochem, Ras10) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (RAS10)
  • immunoprecipitation; human
EMD Millipore Hras antibody (Merck Millipore, 05-516) was used in immunoprecipitation on human samples . Int J Biochem Cell Biol (2014) ncbi
mouse monoclonal (RAS10)
  • western blot; human
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples . BMC Genomics (2013) ncbi
mouse monoclonal (RAS10)
  • western blot; mouse; 1:1000
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on mouse samples at 1:1000. Gastroenterology (2013) ncbi
mouse monoclonal (RAS10)
  • western blot; human; fig 2
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples (fig 2). J Biol Chem (2013) ncbi
mouse monoclonal (RAS 10)
  • western blot; human; fig 6
In order to develop a neuregulin-1 overexpressing transgenic mouse model of neurofibroma-malignant peripheral nerve sheath tumor progression, EMD Millipore Hras antibody (Millipore, RAS10) was used in western blot on human samples (fig 6). Am J Pathol (2013) ncbi
mouse monoclonal (RAS10)
  • western blot; human
EMD Millipore Hras antibody (Millipore, 05-516) was used in western blot on human samples . J Biol Chem (2013) ncbi
Articles Reviewed
  1. Lee Y, Phelps C, Huang T, Mostofian B, Wu L, Zhang Y, et al. High-throughput single-particle tracking reveals nested membrane domains that dictate KRasG12D diffusion and trafficking. elife. 2019;8: pubmed publisher
  2. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  3. Ji J, Yuan J, Guo X, Ji R, Quan Q, Ding M, et al. Harmine suppresses hyper-activated Ras-MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans. Cancer Cell Int. 2019;19:159 pubmed publisher
  4. Jeong W, Park J, Kim W, Ro E, Jeon S, Lee S, et al. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. Nat Commun. 2019;10:295 pubmed publisher
  5. Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23:2083-2092 pubmed publisher
  6. Bigenzahn J, Collu G, Kartnig F, Pieraks M, Vladimer G, Heinz L, et al. LZTR1 is a regulator of RAS ubiquitination and signaling. Science. 2018;362:1171-1177 pubmed publisher
  7. Ruess D, Heynen G, Ciecielski K, Ai J, Berninger A, Kabacaoglu D, et al. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nat Med. 2018;24:954-960 pubmed publisher
  8. Janes M, Zhang J, Li L, Hansen R, Peters U, Guo X, et al. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018;172:578-589.e17 pubmed publisher
  9. Waters A, Ozkan Dagliyan I, Vaseva A, Fer N, Strathern L, Hobbs G, et al. Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies. Sci Signal. 2017;10: pubmed publisher
  10. Jiang X, Bao Y, Liu H, Kou X, Zhang Z, Sun F, et al. VPS34 stimulation of p62 phosphorylation for cancer progression. Oncogene. 2017;36:6850-6862 pubmed publisher
  11. Al Khalaf H, Amir M, Al Mohanna F, Tulbah A, Al Sayed A, Aboussekhra A. Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol. 2017;37: pubmed publisher
  12. Eppler F, Quast T, Kolanus W. Dynamin2 controls Rap1 activation and integrin clustering in human T lymphocyte adhesion. PLoS ONE. 2017;12:e0172443 pubmed publisher
  13. Feng L, Xue D, Chen E, Zhang W, Gao X, Yu J, et al. HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Exp Ther Med. 2016;12:3941-3947 pubmed publisher
  14. Huang C, Huang S, Chien C, Lee H, Yang S, Chang C, et al. Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation. Oncol Lett. 2016;12:4427-4434 pubmed publisher
  15. Li Y, Buijs Gladdines J, Canté Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed publisher
  16. Battram A, Durrant T, Agbani E, Heesom K, Paul D, Piatt R, et al. The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin αIIbβ3 Outside-in Signaling. J Biol Chem. 2017;292:1691-1704 pubmed publisher
  17. Sakata K, Araki K, Nakano H, Nishina T, Komazawa Sakon S, Murai S, et al. Novel method to rescue a lethal phenotype through integration of target gene onto the X-chromosome. Sci Rep. 2016;6:37200 pubmed publisher
  18. Riecken L, Zoch A, Wiehl U, Reichert S, Scholl I, Cui Y, et al. CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. Oncotarget. 2016;7:78242-78254 pubmed publisher
  19. Kenessey I, Kói K, Horváth O, Cserepes M, Molnár D, Izsák V, et al. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models. Oncotarget. 2016;7:79503-79514 pubmed publisher
  20. Dey K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382-391 pubmed publisher
  21. Kotsantis P, Silva L, Irmscher S, Jones R, Folkes L, Gromak N, et al. Increased global transcription activity as a mechanism of replication stress in cancer. Nat Commun. 2016;7:13087 pubmed publisher
  22. Hoare M, Ito Y, Kang T, Weekes M, Matheson N, Patten D, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016;18:979-92 pubmed publisher
  23. Anta B, Pérez Rodríguez A, Castro J, García Domínguez C, Ibiza S, Martínez N, et al. PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes. Cell Death Dis. 2016;7:e2311 pubmed publisher
  24. Ho J, Hsu R, Wu C, Liao G, Gao H, Wang T, et al. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2. Oncotarget. 2016;7:53853-53868 pubmed publisher
  25. Madureira P, Bharadwaj A, Bydoun M, Garant K, O Connell P, Lee P, et al. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget. 2016;7:47720-47737 pubmed publisher
  26. Aguilera O, Muñoz Sagastibelza M, Torrejón B, Borrero Palacios A, del Puerto Nevado L, Martínez Useros J, et al. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer. Oncotarget. 2016;7:47954-47965 pubmed publisher
  27. Yokoi N, Fukata Y, Sekiya A, Murakami T, Kobayashi K, Fukata M. Identification of PSD-95 Depalmitoylating Enzymes. J Neurosci. 2016;36:6431-44 pubmed publisher
  28. Calaf G, Abarca Quinones J. Ras protein expression as a marker for breast cancer. Oncol Lett. 2016;11:3637-3642 pubmed
  29. Canté Barrett K, Spijkers Hagelstein J, Buijs Gladdines J, Uitdehaag J, Smits W, van der Zwet J, et al. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia. Leukemia. 2016;30:1832-43 pubmed publisher
  30. Zhang Y, Lai J, Du Z, Gao J, Yang S, Gorityala S, et al. Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress. Oncotarget. 2016;7:34688-702 pubmed publisher
  31. Carrero Z, Kollareddy M, Chauhan K, Ramakrishnan G, Martinez L. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation. Oncotarget. 2016;7:12554-67 pubmed publisher
  32. Hennig A, Markwart R, Wolff K, Schubert K, Cui Y, Prior I, et al. Feedback activation of neurofibromin terminates growth factor-induced Ras activation. Cell Commun Signal. 2016;14:5 pubmed publisher
  33. White Y, Bagchi A, Van Ziffle J, Inguva A, Bollag G, Zhang C, et al. KRAS insertion mutations are oncogenic and exhibit distinct functional properties. Nat Commun. 2016;7:10647 pubmed publisher
  34. Capell B, Drake A, Zhu J, Shah P, Dou Z, Dorsey J, et al. MLL1 is essential for the senescence-associated secretory phenotype. Genes Dev. 2016;30:321-36 pubmed publisher
  35. Grassilli E, Pisano F, Cialdella A, Bonomo S, Missaglia C, Cerrito M, et al. A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation. Oncogene. 2016;35:4368-78 pubmed publisher
  36. Roßner F, Gieseler C, Morkel M, Royer H, Rivera M, Bläker H, et al. Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer. Oncogenesis. 2016;5:e187 pubmed publisher
  37. Chen Y, Zheng Y, You X, Yu M, Fu G, Su X, et al. Kras Is Critical for B Cell Lymphopoiesis. J Immunol. 2016;196:1678-85 pubmed publisher
  38. Beltrán Sastre V, Benisty H, Burnier J, Berger I, Serrano L, Kiel C. Tuneable endogenous mammalian target complementation via multiplexed plasmid-based recombineering. Sci Rep. 2015;5:17432 pubmed publisher
  39. Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke J, et al. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene. 2016;35:3880-6 pubmed publisher
  40. Ksionda O, Melton A, Bache J, Tenhagen M, Bakker J, Harvey R, et al. RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines. Oncogene. 2016;35:3658-68 pubmed publisher
  41. Dou Z, Xu C, Donahue G, Shimi T, Pan J, Zhu J, et al. Autophagy mediates degradation of nuclear lamina. Nature. 2015;527:105-9 pubmed publisher
  42. Park Y, Kim S, Kwon T, Kim J, Song I, Shin H, et al. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway. Oncogene. 2016;35:3503-13 pubmed publisher
  43. Abu Alainin W, Gana T, Liloglou T, Olayanju A, Barrera L, Ferguson R, et al. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. J Pathol. 2016;238:423-33 pubmed publisher
  44. Hu S, Lu Y, Orr B, Godek K, Mustachio L, Kawakami M, et al. Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown. Mol Cancer Ther. 2015;14:2576-85 pubmed publisher
  45. Cho M, Park J, Choi H, Park M, Won H, Park Y, et al. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression. Nat Commun. 2015;6:7821 pubmed publisher
  46. Nan X, Tamgüney T, Collisson E, Lin L, Pitt C, Galeas J, et al. Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway. Proc Natl Acad Sci U S A. 2015;112:7996-8001 pubmed publisher
  47. Antic I, Biancucci M, Zhu Y, GIUS D, Satchell K. Site-specific processing of Ras and Rap1 Switch I by a MARTX toxin effector domain. Nat Commun. 2015;6:7396 pubmed publisher
  48. Ho J, Nadeem A, Rydström A, Puthia M, Svanborg C. Targeting of nucleotide-binding proteins by HAMLET--a conserved tumor cell death mechanism. Oncogene. 2016;35:897-907 pubmed publisher
  49. Kirschner K, Samarajiwa S, Cairns J, Menon S, Perez Mancera P, Tomimatsu K, et al. Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53. PLoS Genet. 2015;11:e1005053 pubmed publisher
  50. Silva G, Aboussekhra A. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1. Mol Carcinog. 2016;55:525-36 pubmed publisher
  51. Lesur A, Ancheva L, Kim Y, Berchem G, van Oostrum J, Domon B. Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC-MS in PRM mode. Proteomics Clin Appl. 2015;9:695-705 pubmed publisher
  52. Moody S, Schinzel A, Singh S, Izzo F, Strickland M, Luo L, et al. PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling. Oncogene. 2015;34:2061-71 pubmed publisher
  53. Straniero V, Pallavicini M, Chiodini G, Ruggeri P, Fumagalli L, Bolchi C, et al. Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds. Bioorg Med Chem Lett. 2014;24:2924-7 pubmed publisher
  54. Cipriano R, Miskimen K, Bryson B, Foy C, Bartel C, Jackson M. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer. Mol Cancer Res. 2014;12:1156-65 pubmed publisher
  55. Gurung B, Muhammad A, Hua X. Menin is required for optimal processing of the microRNA let-7a. J Biol Chem. 2014;289:9902-8 pubmed publisher
  56. Kloog Y, Mor A. Cytotoxic-T-lymphocyte antigen 4 receptor signaling for lymphocyte adhesion is mediated by C3G and Rap1. Mol Cell Biol. 2014;34:978-88 pubmed publisher
  57. Kiel C, Verschueren E, Yang J, Serrano L. Integration of protein abundance and structure data reveals competition in the ErbB signaling network. Sci Signal. 2013;6:ra109 pubmed publisher
  58. Kostenko S, Jensen K, Moens U. Phosphorylation of heat shock protein 40 (Hsp40/DnaJB1) by mitogen-activated protein kinase-activated protein kinase 5 (MK5/PRAK). Int J Biochem Cell Biol. 2014;47:29-37 pubmed publisher
  59. Zaganjor E, Osborne J, Weil L, Díaz Martínez L, Gonzales J, Singel S, et al. Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells. Oncogene. 2014;33:5457-66 pubmed publisher
  60. Segatto M, Manduca A, Lecis C, Rosso P, Jozwiak A, Swiezewska E, et al. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats. Neuropsychopharmacology. 2014;39:841-54 pubmed publisher
  61. Shain A, Salari K, Giacomini C, Pollack J. Integrative genomic and functional profiling of the pancreatic cancer genome. BMC Genomics. 2013;14:624 pubmed publisher
  62. Philip B, Roland C, Daniluk J, Liu Y, Chatterjee D, Gomez S, et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013;145:1449-58 pubmed publisher
  63. Haeussler D, Pimentel D, Hou X, Burgoyne J, Cohen R, Bachschmid M. Endomembrane H-Ras controls vascular endothelial growth factor-induced nitric-oxide synthase-mediated endothelial cell migration. J Biol Chem. 2013;288:15380-9 pubmed publisher
  64. BENTLEY C, Jurinka S, Kljavin N, Vartanian S, Ramani S, Gonzalez L, et al. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. Biochem J. 2013;452:313-20 pubmed publisher
  65. Kazmi S, Byer S, Eckert J, Turk A, Huijbregts R, Brossier N, et al. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis. Am J Pathol. 2013;182:646-67 pubmed publisher
  66. Vartanian S, BENTLEY C, Brauer M, Li L, Shirasawa S, Sasazuki T, et al. Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines. J Biol Chem. 2013;288:2403-13 pubmed publisher
  67. Lau R, Niu M, Pratt M. cIAP2 represses IKK?/?-mediated activation of MDM2 to prevent p53 degradation. Cell Cycle. 2012;11:4009-19 pubmed publisher
  68. Tian W, Boss G, Cohen D. Ras signaling in the inner medullary cell response to urea and NaCl. Am J Physiol Cell Physiol. 2000;278:C372-80 pubmed